Quote | Super Quote
ETF Search
Code: Name︰
Return Time Period: Returns:
Premium/Discount(%): % Yield︰
Asset:
All    
Underlying Asset:
Hot ETF︰
Search Result ：3 Records
Fund Overview
Default Order Ordered by Asset
CodeNameUnderlying AssetNominal%ChangeTurnoverdescendingMKT CapPrem/DiscountRelated Information
03525CAM INNODRUGS
Break 52W Lo		FTSE ETF Connect Innovative Drugs Index (net total return version)upHKD
9.470		+0.477%0.000601.345M+0.65%Details | Quote
41525CAM INNODRUGS-U
Break 52W Lo		FTSE ETF Connect Innovative Drugs Index (net total return version)upUSD
1.206		+0.333%0.00076.581M+0.42%Details | Quote
83525CAM INNODRUGS-R
Break 52W Lo		FTSE ETF Connect Innovative Drugs Index (net total return version)upRMB
8.055		+0.436%0.000511.493M+0.51%Details | Quote
Remark: Quote data is at least 15-min delayed. Data updated on: 23/10/2026 16:40
Fund return is not including dividend. Data updated on: 22/10/2026 08:02
Net asset value is subjected to the latest information released by issuers and daily updated. Beware of delayed calculation of Premium/Discount(%).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.